– Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva, an anti-CD20 monoclonal antibody designed for enhanced B cell depletion – – Gazyva has the potential to be a ...
Identifying lipid-linked genetic pathways in Asian Indians offers insights into diabetes and heart disease, crucial for ...
In a recent study published in the journal Nature Metabolism, researchers mapped the plasma metabolome to its relationship with human health and disease. Metabolites provide a unique readout of health ...
The MarketWatch News Department was not involved in the creation of this content. Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients ...
Please provide your email address to receive an email when new articles are posted on . Low placental growth factor had a significant association with early-onset preeclampsia for women with sickle ...
Investigator-initiated data from Houston Methodist Hospital showed LD IL-2 reduced proinflammatory factors, both systemically and within the central nervous system, while demonstrating statistically ...
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results